Intersect ENT Competitors and Similar CompaniesClear all
Intersect ENT's competitors and similar companies include Lyra Therapeutics and OptiNose.
 Intersect ENT Intersect ENT (also known as Medtronic Ear, Nose & Throat) is an ear, nose, and throat medical technology company. |  Lyra Therapeutics Lyra Therapeutics is a therapeutics company focused on the development of integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. | ||
Founding Date | Founding Date 2003 | Founding Date 2005 | Founding Date 2000 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations Menlo Park, US HQ | Locations Watertown, US HQ | Locations Morrisville, US HQ Oslo, NO Swindon, GB |
Employees | Employees 4337% increase | Employees 34 | Employees 2048% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 17.4 m | Valuation ($) 118.1 m |
Financial | |||
Revenue (est.) | Revenue (est.) $106.7m (FY, 2021) | Revenue (est.) $398k (FY, 2025) | Revenue (est.) $78.2m (FY, 2024) |
Cost of goods | Cost of goods $30m (FY, 2021) | Cost of goods N/A | Cost of goods $7.2m (FY, 2024) |
Gross profit | Gross profit $76.7m (FY, 2021) | Gross profit N/A | Gross profit $71m (FY, 2024) |
Net income | Net income ($159.6m) (FY, 2021) | Net income ($28.9m) (FY, 2025) | Net income ($21.5m) (FY, 2024) |
Operating ⚠ | |||
Patents (US) | Patents (US) 30 (FY, 2016) | Patents (US) N/A | Patents (US) 43 (Jun, 2017) |
Trademarks (US) | Trademarks (US) 4 (FY, 2016) | Trademarks (US) N/A | Trademarks (US) 3 (Jun, 2017) |
Funding | |||
Total funding raised | Total funding raised $ 102.9m | Total funding raised $ 59.5m | Total funding raised $ 120.5m |
For sources of this data, please see the company profile
View Company Profiles
Lyra Therapeutics
HQ
Watertown, US
Employees
34
Lyra Therapeutics is a therapeutics company focused on the development of integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases.
View company
OptiNose
HQ
Morrisville, US
Employees
204↓ 8% decrease
OptiNose develops nasal drug delivery technologies and combination drug-device therapies.
View company